-
All Resources
(choose a category)
-
All Resources
-
Evidence
Evidence, advice, guidance and standards
-
Improvement
Improvement and implementation support
-
Scrutiny
Assurance, scrutiny, measurement and reporting
-
-
Healthcare Area
- Blood and immune system
- Cancer
- Cardiovascular system
- Dermatology
- Digestive system
- Ear, nose and throat
- Endocrine, nutritional and metabolic
- Eye
- Genitourinary system
- Infectious disease
- Injuries, accidents and wounds
- Mental and behavioural disorders
- Mouth and dental
- Musculoskeletal system
- Nervous system
- Obstetrics and gynaecology
- Respiratory system
-
Resource Type
- NICE Guidance
- Programme
- Year
- Page 1 of 23
- next
224 results found filtered by NICE Guidance Remove NICE Guidance Filter Clear Search
-
NICE MTA guidance no 278 - Omalizumab for treating severe persistent allergic asthma
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance no 280 - Rheumatoid arthritis (2nd line) - abatacept (rapid review of TA 234)
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance no 281 - Canakinumab for gout – terminated appraisal
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance no 282 - Idiopathic pulmonary fibrosis - pirfenidone
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE MTA Guidance no 279 - Percutaneous vertebroplasty and percutaneous balloon kyphoplasty
- Published
- 24 April 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance 277 - Methylnaltrexone (Terminated Appraisal)
- Published
- 27 March 2013
- Cycle of Improvement
- Evidence
-
NICE MTA Guidance No 276 – Colistimethate sodium and tobramycin for pseudomonas lung infection in cystic fibrosis
- Published
- 27 March 2013
- Cycle of Improvement
- Evidence
-
NICE STA guidance 275 - Apixaban for preventing stroke and systemic embolism
- Published
- 27 February 2013
- Cycle of Improvement
- Evidence
-
NICE STA 274 Ranibizumab for the treatment of diabetic macular oedema (rapid review of TA237)
- Published
- 27 February 2013
- Cycle of Improvement
- Evidence
-
NICE STA Guidance 272 - Vinflunine for advanced or metastatic transitional cell carcinoma of the urothelial tract
- Published
- 23 January 2013
- Cycle of Improvement
- Evidence